Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies

Zhou, DY; Chan, JFW; Zhou, B; Zhou, RH; Li, S; Shan, SS; Liu, L; Zhang, AJ; Chen, SJ; Chan, CCS; Xu, HR; Poon, VKM; Yuan, SF; Li, C; Chik, KKH; Chan, CCY; Cao, JL; Chan, CY; Kwan, KY; Du, ZL; Lau, TTK; Zhang, Q; Zhou, J; To, KKW; Zhang, LQ; Ho, DD; Yuen, KY; Chen, ZW

Chen, ZW (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, AIDS Inst, Pokfulam, Hong Kong, Peoples R China.; Yuen, KY; Chen, ZW (corresponding author), Univ Hong Kong, State Key Lab Emerging Infect Dis, Pokfulam, Hong Kong, Peoples R China.; Yuen, KY; Chen, ZW (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China.; Yuen, KY (corresponding author), Univ Hong Kong, Carol Yu Ctr Infect, Pokfulam, Hong Kong, Peoples R China.; Yue

CELL HOST & MICROBE, 2021; 29 (4): 551

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is characterized by a burst in the upper respiratory portal for high transmissibility. To......

Full Text Link